Slideshow
Author(s):
New research may help doctors determine when (and when not) to test for antiglutamate decarboxylase antibodies in patients with neurological disorders and psychiatric symptoms.
This Week on NeurologyLive® — October 28, 2024
Episode 123: Previewing Cleveland Clinic's Epilepsy Summit
NeurologyLive® Brain Games: October 20, 2024
Episode 116: Understanding Vorasidenib's Therapeutic Benefit on Neurocognition, Seizure Control in Diffuse Gliomas
This Week on NeurologyLive® — October 7, 2024
NeurologyLive® Friday 5 — October 4, 2024